Probiotics in the Management of Crohn's disease and Ulcerative Colitis

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|20|28|4556-4560

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.20, Iss.28, 2014-08, pp. : 4556-4560

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Dietary Supplement Therapies for Inflammatory Bowel Disease: Crohn’s Disease and Ulcerative Colitis

By  

Current Pharmaceutical Design, Vol. 22, Iss. 2, 2016-01 ,pp. : 180-188

Bentham Science Publishers

Access to resources Recommend Favorite

Commonalities and Differences Between Crohn's Disease and Ulcerative Colitis: The Genetic Clues to their Interpretation

By  

Inflammation & Allergy-Drug Targets (Formerly Current Drug Targets - Inflammation & Allergy), Vol. 10, Iss. 6, 2011-12 ,pp. : 447-454

Bentham Science Publishers

Access to resources Recommend Favorite

Ulcerative colitis, but not Crohn's disease, is linked to previous exposure to isotretinoin

By  

Reactions Weekly, Vol. 1, Iss. 1306, 2010-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite

Lessons to Learn from Crohn's Disease Clinical Trials: Implications for Ulcerative Colitis

By  

Current Drug Targets, Vol. 12, Iss. 10, 2011-09 ,pp. : 1467-1477

Bentham Science Publishers

Access to resources Recommend Favorite

Oral Delayed-Release Mesalazine: A Review of its Use in Ulcerative Colitis and Crohn's Disease

By Prakash A.   Markham A.  

Drugs, Vol. 57, Iss. 3, 1999-03 ,pp. : 383-408

Adis International

Access to resources Recommend Favorite